Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?
<p>Abstract</p> <p>Dyslipidemia, and inflammatory markers: high-sensitivity C-reactive protein (hs-CRP), myeloperoxidase (MPO), lipoprotein associated phospholipase A<sub>2</sub>(Lp-PLA<sub>2</sub>), and lipid peroxides (LP) are insufficient to predict the o...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-05-01
|
| Series: | Lipids in Health and Disease |
| Online Access: | http://www.lipidworld.com/content/7/1/19 |
| _version_ | 1819203542540353536 |
|---|---|
| author | Das Undurti N |
| author_facet | Das Undurti N |
| author_sort | Das Undurti N |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Dyslipidemia, and inflammatory markers: high-sensitivity C-reactive protein (hs-CRP), myeloperoxidase (MPO), lipoprotein associated phospholipase A<sub>2</sub>(Lp-PLA<sub>2</sub>), and lipid peroxides (LP) are insufficient to predict the onset, extent, and prognosis of CHD. Lipoxins (LXs), resolvins, and protectins are derived from ω-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and ω-6 arachidonic acid in the presence of aspirin; whereas nitrolipids are formed due to the interaction between polyunsaturated fatty acids and nitric oxide (NO). LXs, resolvins, protectins, and nitrolipids are endogenous anti-inflammatory lipid molecules that inhibit production of interleukin-6 (IL-6) and tumor necrosis factor- α (TNF-α), suppress free radical generation, enhance NO generation; and accelerate tissue repair. Thus, beneficial actions of EPA/DHA and aspirin in CHD could be attributed to the formation of LXs, resolvins, protectins, and nitrolipids and suggest that their plasma levels aid in the prediction and prognosis of CHD.</p> |
| first_indexed | 2024-12-23T04:21:34Z |
| format | Article |
| id | doaj.art-64c1b9a4e0f747e8a344eed959d83824 |
| institution | Directory Open Access Journal |
| issn | 1476-511X |
| language | English |
| last_indexed | 2024-12-23T04:21:34Z |
| publishDate | 2008-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Lipids in Health and Disease |
| spelling | doaj.art-64c1b9a4e0f747e8a344eed959d838242022-12-21T18:00:14ZengBMCLipids in Health and Disease1476-511X2008-05-01711910.1186/1476-511X-7-19Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?Das Undurti N<p>Abstract</p> <p>Dyslipidemia, and inflammatory markers: high-sensitivity C-reactive protein (hs-CRP), myeloperoxidase (MPO), lipoprotein associated phospholipase A<sub>2</sub>(Lp-PLA<sub>2</sub>), and lipid peroxides (LP) are insufficient to predict the onset, extent, and prognosis of CHD. Lipoxins (LXs), resolvins, and protectins are derived from ω-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and ω-6 arachidonic acid in the presence of aspirin; whereas nitrolipids are formed due to the interaction between polyunsaturated fatty acids and nitric oxide (NO). LXs, resolvins, protectins, and nitrolipids are endogenous anti-inflammatory lipid molecules that inhibit production of interleukin-6 (IL-6) and tumor necrosis factor- α (TNF-α), suppress free radical generation, enhance NO generation; and accelerate tissue repair. Thus, beneficial actions of EPA/DHA and aspirin in CHD could be attributed to the formation of LXs, resolvins, protectins, and nitrolipids and suggest that their plasma levels aid in the prediction and prognosis of CHD.</p>http://www.lipidworld.com/content/7/1/19 |
| spellingShingle | Das Undurti N Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? Lipids in Health and Disease |
| title | Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? |
| title_full | Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? |
| title_fullStr | Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? |
| title_full_unstemmed | Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? |
| title_short | Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? |
| title_sort | can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease |
| url | http://www.lipidworld.com/content/7/1/19 |
| work_keys_str_mv | AT dasundurtin canendogenouslipidmoleculesserveaspredictorsandprognosticmarkersofcoronaryheartdisease |